Transparency data

Voluntary scheme aggregate net sales and payment information: February 2021

Information on how the 2019 voluntary scheme for branded medicines pricing and access is controlling spend on branded medicines in the NHS.

Documents

Details

This document sets out the NHS’s quarterly aggregate net sales and payment information on pharmaceuticals for February 2021.

The 2019 voluntary scheme for branded medicines pricing and access is an agreement between DHSC and the Association of the British Pharmaceutical Industry (ABPI) on getting the best value and most effective medicines into use more quickly.

Updates to this page

Published 1 March 2021

Sign up for emails or print this page